MedPath

Sulpiride

Generic Name
Sulpiride
Drug Type
Small Molecule
Chemical Formula
C15H23N3O4S
CAS Number
15676-16-1
Unique Ingredient Identifier
7MNE9M8287
Background

Sulpiride first appeared in published literature in 1967. Clinical studies show a greater effect on treating the negative symptoms of schizophrenia rather than positive symptoms at low doses, though the effects are more equal at higher doses.

Sulpiride is not approved by the FDA, Health Canada, or the EMA; though it is approved in individual European countries.

Indication

Sulpiride is indicated for the treatment of acute and chronic schizophrenia.

Associated Conditions
Acute Schizophrenia, Chronic Schizophrenia, Constipation, Dyspepsia, Menière's Disease, Nausea, Psychosis, Schizophrenia, Vomiting

Dopamine and Cognition

Not Applicable
Completed
Conditions
Interaction of Sulpiride, Average Reward Rate and Cognitive Effort
Sulpiride's Effect on Striatal BOLD Signal During Working Memory Gating
Interaction of Sulpiride, Average Reward Rate and Evidence Accumulation
Interventions
First Posted Date
2023-06-01
Last Posted Date
2023-09-21
Lead Sponsor
Donders Centre for Cognitive Neuroimaging
Target Recruit Count
47
Registration Number
NCT05884671
Locations
🇳🇱

Donders Centre for Cognition, Radboud University, Nijmegen, Gelderland, Netherlands

The Role of Dopamine, Reward Learning and Prefrontal Activity in Expectation-induced Mood Enhancement

Not Applicable
Completed
Conditions
Placebo Effect on Mood Improvement
Interventions
Drug: Placebo
Behavioral: High expectation manipulation
Behavioral: Low expectation manipulation
First Posted Date
2022-01-26
Last Posted Date
2024-01-16
Lead Sponsor
Philipps University Marburg Medical Center
Target Recruit Count
297
Registration Number
NCT05208294
Locations
🇩🇪

Department of Psychology, Differential Psychology and Personality Research, Philipps-University of Marburg, Marburg, Hessen, Germany

The Effect of Antiemetics on Bowel Preparation Before Colonoscopy

Phase 4
Conditions
Bowel Preparation
Interventions
First Posted Date
2020-10-12
Last Posted Date
2020-10-12
Lead Sponsor
RenJi Hospital
Target Recruit Count
200
Registration Number
NCT04583111
Locations
🇨🇳

Shengliang Chen, Shanghai, China

Sulpiride Versus Placebo for Reducting Hot Flushes During Climacteric

Phase 3
Completed
Conditions
Menopausal Syndrome
Hot Flashes
Interventions
Drug: Placebo
First Posted Date
2016-04-25
Last Posted Date
2019-01-14
Lead Sponsor
Hospital de Clinicas de Porto Alegre
Target Recruit Count
28
Registration Number
NCT02749747
Locations
🇧🇷

Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande Do Sul, Brazil

Pharmacovigilance in Gerontopsychiatric Patients

Phase 3
Terminated
Conditions
Dementia
Depression
Schizophrenia
Psychosomatic Disorders
Anxiety Disorders
Interventions
First Posted Date
2015-03-02
Last Posted Date
2018-02-28
Lead Sponsor
Hannover Medical School
Target Recruit Count
407
Registration Number
NCT02374567
Locations
🇩🇪

Bezirkskrankenhaus Augsburg, Augsburg, Germany

🇩🇪

Krankenhaus Hedwigshöhe, Berlin, Germany

🇩🇪

Hannover Medical School, Hannover, Germany

and more 2 locations

Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic Patients

First Posted Date
2014-12-04
Last Posted Date
2018-10-11
Lead Sponsor
Technical University of Munich
Target Recruit Count
21
Registration Number
NCT02307396
Locations
🇩🇪

Psychiatrische Klinik und Poliklinik fuer Psychiatrie und Psychotherapie der Technischen Universitaet Muenchen am Klinikum rechts der Isar, Munich, Bavaria, Germany

Interpersonal Psychotherapy for Treatment Resistant Depression

First Posted Date
2013-07-11
Last Posted Date
2013-07-11
Lead Sponsor
Hospital de Clinicas de Porto Alegre
Target Recruit Count
74
Registration Number
NCT01896349
Locations
🇧🇷

Federal University of Rio Grande do Sul / Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, RS, Brazil

Therapeutic Drug Monitoring and Pharmacokinetic Compartmental Analysis of Sulpiride After Oral Administration to Healthy Volunteers

Not Applicable
Completed
Conditions
Healthy
Interventions
First Posted Date
2013-01-29
Last Posted Date
2013-01-29
Lead Sponsor
Damanhour University
Target Recruit Count
16
Registration Number
NCT01777685
Locations
🇪🇬

Pharmaceutics Department, Faculty of Pharmacy, Damanhour University, Damanhour, Egypt

Dopaminergic Modulation of Choroidal Blood Flow Changes During Dark/Light Transitions

Not Applicable
Completed
Conditions
Regional Blood Flow
Ocular Physiology
Interventions
First Posted Date
2006-01-23
Last Posted Date
2008-07-09
Lead Sponsor
Medical University of Vienna
Target Recruit Count
21
Registration Number
NCT00280501
Locations
🇦🇹

Department of Clinical Pharmacology, Vienna, Austria

© Copyright 2025. All Rights Reserved by MedPath